Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1021-335X Online ISSN: 1791-2431
Journal Cover
December-2020 Volume 44 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
December-2020 Volume 44 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

Protein disulfide isomerase A1 regulates breast cancer cell immunorecognition in a manner dependent on redox state

  • Authors:
    • Rashed Alhammad
    • Sasiprapa Khunchai
    • Nopprarat Tongmuang
    • Thawornchai Limjindaporn
    • Pa‑Thai Yenchitsomanus
    • Luciano Mutti
    • Marija Krstic‑Demonacos
    • Constantinos Demonacos
  • View Affiliations / Copyright

    Affiliations: Faculty of Biology Medicine and Health, School of Health Sciences, Division of Pharmacy and Optometry, University of Manchester, Manchester M13 9PT, UK, Department of Anatomy, Faculty of Medical Science, Naresuan University, Phitsanulok 65000, Thailand, Division of Molecular Medicine, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand, Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA 19122, USA, University of Salford, School of Science, Engineering and Environment, Salford M5 4WT, UK
    Copyright: © Alhammad et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 2406-2418
    |
    Published online on: October 20, 2020
       https://doi.org/10.3892/or.2020.7816
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Oxidoreductase protein disulphide isomerases (PDI) are involved in the regulation of a variety of biological processes including the modulation of endoplasmic reticulum (ER) stress, unfolded protein response (UPR), ER‑mitochondria communication and the balance between pro‑survival and pro‑death pathways. In the current study the role of the PDIA1 family member in breast carcinogenesis was investigated by measuring ROS generation, mitochondrial membrane disruption, ATP production and HLA‑G protein levels on the surface of the cellular membrane in the presence or absence of PDIA1. The results showed that this enzyme exerted pro‑apoptotic effects in estrogen receptor (ERα)‑positive breast cancer MCF‑7 and pro‑survival in triple negative breast cancer (TNBC) MDA‑MB‑231 cells. ATP generation was upregulated in PDIA1‑silenced MCF‑7 cells and downregulated in PDIA1‑silenced MDA‑MB‑231 cells in a manner dependent on the cellular redox status. Furthermore, MCF‑7 and MDA‑MB‑231 cells in the presence of PDIA1 expressed higher surface levels of the non‑classical human leukocyte antigen (HLA‑G) under oxidative stress conditions. Evaluation of the METABRIC datasets showed that low PDIA1 and high HLA‑G mRNA expression levels correlated with longer survival in both ERα‑positive and ERα‑negative stage 2 breast cancer patients. In addition, analysis of the PDIA1 vs. the HLA‑G mRNA ratio in the subgroup of the living stage 2 breast cancer patients exhibiting low PDIA1 and high HLA‑G mRNA levels revealed that the longer the survival time of the ratio was high PDIA1 and low HLA‑G mRNA and occurred predominantly in ERα‑positive breast cancer patients whereas in the same subgroup of the ERα‑negative breast cancer mainly this ratio was low PDIA1 and high HLA‑G mRNA. Taken together these results provide evidence supporting the view that PDIA1 is linked to several hallmarks of breast cancer pathways including the process of antigen processing and presentation and tumor immunorecognition.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1 

Liou GY and Storz P: Reactive oxygen species in cancer. Free Radic Res. 44:479–496. 2010. View Article : Google Scholar : PubMed/NCBI

2 

Schieber M and Chandel NS: ROS function in redox signaling and oxidative stress. Curr Biol. 24:R453–R462. 2014. View Article : Google Scholar : PubMed/NCBI

3 

Eletto D, Chevet E, Argon Y and Appenzeller-Herzog C: Redox controls UPR to control redox. J Cell Sc. 127:3649–3658. 2014. View Article : Google Scholar

4 

Almanza A, Carlesso A, Chintha C, Creedican S, Doultsinos D, Leuzzi B, Luis A, McCarthy N, Montibeller L, More S, et al: Endoplasmic reticulum stress signalling-from basic mechanisms to clinical applications. FEBS J. 286:241–278. 2019. View Article : Google Scholar : PubMed/NCBI

5 

Oakes SA: Endoplasmic reticulum proteostasis: A key checkpoint in cancer. Am J Physiol Cell Physiol. 312:C93–C102. 2017. View Article : Google Scholar : PubMed/NCBI

6 

Zhang Z, Zhang L, Zhou L, Lei Y, Zhang Y and Huang C: Redox signaling and unfolded protein response coordinate cell fate decisions under ER stress. Redox Biol. 25:1010472018. View Article : Google Scholar : PubMed/NCBI

7 

Kranz P, Neumann F, Wolf A, Classen F, Pompsch M, Ocklenburg T, Baumann J, Janke K, Baumann M, Goepelt K, et al: PDI is an essential redox-sensitive activator of PERK during the unfolded protein response (UPR). Cell Death Dis. 8:e29862017. View Article : Google Scholar : PubMed/NCBI

8 

Okada K, Fukui M and Zhu BT: Protein disulfide isomerase mediates glutathione depletion-induced cytotoxicity. Biochem Biophys Res Commun. 477:495–502. 2016. View Article : Google Scholar : PubMed/NCBI

9 

Grek C and Townsend DM: Protein disulfide isomerase superfamily in disease and the regulation of apoptosis. Endoplasmic Reticulum Stress Dis. 1:4–17. 2014.PubMed/NCBI

10 

Ali Khan H and Mutus B: Protein disulfide isomerase a multifunctional protein with multiple physiological roles. Front Chem. 2:702014. View Article : Google Scholar : PubMed/NCBI

11 

Wang C, Li W, Ren J, Fang J, Ke H, Gong W, Feng W and Wang CC: Structural insights into the redox-regulated dynamic conformations of human protein disulfide isomerase. Antioxid Redox Signal. 19:36–45. 2013. View Article : Google Scholar : PubMed/NCBI

12 

Yu J, Li T, Liu Y, Wang X, Zhang J, Shi G, Lou J and Wang L, Wang CC and Wang L: Phosphorylation switches protein disulfide isomerase activity to maintain proteostasis and attenuate ER stress. EMBO J. 39:e1038412020. View Article : Google Scholar : PubMed/NCBI

13 

Turano C, Coppari S, Altieri F and Ferraro A: Proteins of the PDI family: Unpredicted non-ER locations and functions. J Cell Physiol. 193:154–163. 2002. View Article : Google Scholar : PubMed/NCBI

14 

Parakh S and Atkin JD: Novel roles for protein disulphide isomerase in disease states: A double edged sword? Front Cell Dev Biol. 3:302015. View Article : Google Scholar : PubMed/NCBI

15 

Zhao G, Lu H and Li C: Proapoptotic activities of protein disulfide isomerase (PDI) and PDIA3 protein, a role of the Bcl-2 protein Bak. J Biol Chem. 290:8949–8963. 2015. View Article : Google Scholar : PubMed/NCBI

16 

Ghanbari Movahed Z, Rastegari-Pouyani M, Mohammadi MH and Mansouri K: Cancer cells change their glucose metabolism to overcome increased ROS: One step from cancer cell to cancer stem cell? Biomed Pharmacother. 112:1086902019. View Article : Google Scholar : PubMed/NCBI

17 

Higuchi T, Watanabe Y and Waga I: Protein disulfide isomerase suppresses the transcriptional activity of NF-kappaB. Biochem Biophys Res Commun. 318:46–52. 2004. View Article : Google Scholar : PubMed/NCBI

18 

Goplen D, Wang J, Enger PO, Tysnes BB, Terzis AJ, Laerum OD and Bjerkvig R: Protein disulfide isomerase expression is related to the invasive properties of malignant glioma. Cancer Res. 66:9895–9902. 2006. View Article : Google Scholar : PubMed/NCBI

19 

Reverendo M, Mendes A, Arguello RJ, Gatti E and Pierre P: At the crossway of ER-stress and proinflammatory responses. FEBS J. 286:297–310. 2019. View Article : Google Scholar : PubMed/NCBI

20 

Obacz J, Avril T, Rubio-Patino C, Bossowski JP, Igbaria A, Ricci JE and Chevet E: Regulation of tumor-stroma interactions by the unfolded protein response. FEBS J. 286:279–296. 2019. View Article : Google Scholar : PubMed/NCBI

21 

Lamers M, Berlin I and Neefjes J: Antigen presentation: Visualizing the MHC Class I peptide-loading bottleneck. Curr Biol. 28:R83–R86. 2018. View Article : Google Scholar : PubMed/NCBI

22 

Kang K, Park B, Oh C, Cho K and Ahn K: A role for protein disulfide isomerase in the early folding and assembly of MHC class I molecules. Antioxid Redox Signal. 11:2553–2561. 2009. View Article : Google Scholar : PubMed/NCBI

23 

Park B, Lee S, Kim E, Cho K, Riddell SR, Cho S and Ahn K: Redox regulation facilitates optimal peptide selection by MHC class I during antigen processing. Cell. 127:369–382. 2006. View Article : Google Scholar : PubMed/NCBI

24 

Cho K, Cho S, Lee SO, Oh C, Kang K, Ryoo J, Lee S, Kang S and Ahn K: Redox-regulated peptide transfer from the transporter associated with antigen processing to major histocompatibility complex class I molecules by protein disulfide isomerase. Antioxid Redox Signal. 15:621–633. 2011. View Article : Google Scholar : PubMed/NCBI

25 

Lee S, Park B, Kang K and Ahn K: Redox-regulated export of the major histocompatibility complex class I-peptide complexes from the endoplasmic reticulum. Mol Biol Cell. 20:3285–3294. 2009. View Article : Google Scholar : PubMed/NCBI

26 

Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et al: The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2:401–404. 2012. View Article : Google Scholar : PubMed/NCBI

27 

Soares Moretti AI and Martins Laurindo FR: Protein disulfide isomerases: Redox connections in and out of the endoplasmic reticulum. Arch Biochem Biophys. 617:106–119. 2017. View Article : Google Scholar : PubMed/NCBI

28 

Guazzelli A, Meysami P, Bakker E, Demonacos C, Giordano A, Krstic-Demonacos M and Mutti L: BAP1 status determines the sensitivity of malignant mesothelioma cells to gemcitabine treatment. Int J Mol Sci. 20:4292019. View Article : Google Scholar

29 

Forkink M, Smeitink JA, Brock R, Willems PH and Koopman WJ: Detection and manipulation of mitochondrial reactive oxygen species in mammalian cells. Biochim Biophys Acta. 1797:1034–1044. 2010. View Article : Google Scholar : PubMed/NCBI

30 

Cereda M, Gambardella G, Benedetti L, Iannelli F, Patel D, Basso G, Guerra RF, Mourikis TP, Puccio I, Sinha S, et al: Patients with genetically heterogeneous synchronous colorectal cancer carry rare damaging germline mutations in immune-related genes. Nat Commun. 7:120722016. View Article : Google Scholar : PubMed/NCBI

31 

Barrey E, Saint-Auret G, Bonnamy B, Damas D, Boyer O and Gidrol X: Pre-microRNA and mature microRNA in human mitochondria. PLoS One. 6:e202202011. View Article : Google Scholar : PubMed/NCBI

32 

Zibara K, Zeidan A, Bjeije H, Kassem N, Badran B and El-Zein N: ROS mediates interferon gamma induced phosphorylation of Src, through the Raf/ERK pathway, in MCF-7 human breast cancer cell line. J Cell Commun Signal. 11:57–67. 2017. View Article : Google Scholar : PubMed/NCBI

33 

Oh SY, Sohn YW, Park JW, Park HJ, Jeon HM, Kim TK, Lee JS, Jung JE, Jin X, Chung YG, et al: Selective cell death of oncogenic Akt-transduced brain cancer cells by etoposide through reactive oxygen species mediated damage. Mol Cancer Ther. 6:2178–2187. 2007. View Article : Google Scholar : PubMed/NCBI

34 

Hodny Z, Reinis M, Hubackova S, Vasicova P and Bartek J: Interferon gamma/NADPH oxidase defense system in immunity and cancer. Oncoimmunology. 5:e10804162016. View Article : Google Scholar : PubMed/NCBI

35 

Laurindo FR, Pescatore LA and Fernandes Dde C: Protein disulfide isomerase in redox cell signaling and homeostasis. Free Radic Biol Med. 52:1954–1969. 2012. View Article : Google Scholar : PubMed/NCBI

36 

Hegedűs C, Kovács K, Polgár Z, Regdon Z, Szabó É, Robaszkiewicz A, Forman HJ, Martner A and Virág L: Redox control of cancer cell destruction. Redox Biol. 16:59–74. 2018. View Article : Google Scholar : PubMed/NCBI

37 

Traverso N, Ricciarelli R, Nitti M, Marengo B, Furfaro AL, Pronzato MA, Marinari UM and Domenicotti C: Role of glutathione in cancer progression and chemoresistance. Oxid Med Cell Longev. 2013:9729132013. View Article : Google Scholar : PubMed/NCBI

38 

Bulleid NJ: Disulfide bond formation in the mammalian endoplasmic reticulum. Cold Spring Harb Perspect Biol. 4:a0132192012. View Article : Google Scholar : PubMed/NCBI

39 

Herrera-Cruz MS and Simmen T: Cancer: Untethering mitochondria from the endoplasmic reticulum? Front Oncol. 7:1052017. View Article : Google Scholar : PubMed/NCBI

40 

Koczian F, Naglo O, Vomacka J, Vick B, Servatius P, Zisis T, Hettich B, Kazmaier U, Sieber SA, Jeremias I, et al: Targeting the endoplasmic reticulum-mitochondria interface sensitizes leukemia cells to cytostatics. Haematologica. 104:546–555. 2019. View Article : Google Scholar : PubMed/NCBI

41 

Marchi S, Patergnani S and Pinton P: The endoplasmic reticulum-mitochondria connection: One touch, multiple functions. Biochim Biophys Acta. 1837:461–469. 2014. View Article : Google Scholar : PubMed/NCBI

42 

Kerkhofs M, Bittremieux M, Morciano G, Giorgi C, Pinton P, Parys JB and Bultynck G: Emerging molecular mechanisms in chemotherapy: Ca(2+) signaling at the mitochondria-associated endoplasmic reticulum membranes. Cell Death Dis. 9:3342018. View Article : Google Scholar : PubMed/NCBI

43 

Yoboue ED, Sitia R and Simmen T: Redox crosstalk at endoplasmic reticulum (ER) membrane contact sites (MCS) uses toxic waste to deliver messages. Cell Death Dis. 9:3312018. View Article : Google Scholar : PubMed/NCBI

44 

Wacquier B, Combettes L and Dupont G: Cytoplasmic and mitochondrial calcium signaling: A two-way relationship. Cold Spring Harb Perspect Biol. 11:a0351392019. View Article : Google Scholar : PubMed/NCBI

45 

So JS: Roles of endoplasmic reticulum stress in immune responses. Mol Cells. 41:705–716. 2018.PubMed/NCBI

46 

Kukita K, Tamura Y, Tanaka T, Kajiwara T, Kutomi G, Saito K, Okuya K, Takaya A, Kanaseki T, Tsukahara T, et al: Cancer-associated oxidase ERO1-α regulates the expression of MHC class I molecule via oxidative folding. J Immunol. 194:4988–4996. 2015. View Article : Google Scholar : PubMed/NCBI

47 

Kim Y, Kang K, Kim I, Lee YJ, Oh C, Ryoo J, Jeong E and Ahn K: Molecular mechanisms of MHC class I-antigen processing: Redox considerations. Antioxid Redox Signal. 11:907–936. 2009. View Article : Google Scholar : PubMed/NCBI

48 

Binder RJ: Functions of heat shock proteins in pathways of the innate and adaptive immune system. J Immunol. 193:5765–5771. 2014. View Article : Google Scholar : PubMed/NCBI

49 

Allen RL: Non-classical immunology. Genome Biol. 2:REPORTS40042001. View Article : Google Scholar : PubMed/NCBI

50 

da Silva GB, Silva TG, Duarte RA, Neto NL, Carrara HH, Donadi EA, Goncalves MA, Soares EG and Soares CP: Expression of the classical and nonclassical HLA molecules in breast cancer. Int J Breast Cancer. 2013:2504352013. View Article : Google Scholar : PubMed/NCBI

51 

Sivori S, Vacca P, Del Zotto G, Munari E, Mingari MC and Moretta L: Human NK cells: Surface receptors, inhibitory checkpoints, and translational applications. Cell Mol Immunol. 16:430–441. 2019. View Article : Google Scholar : PubMed/NCBI

52 

Morandi F, Rizzo R, Fainardi E, Rouas-Freiss N and Pistoia V: Recent advances in our understanding of HLA-G biology: Lessons from a wide spectrum of human diseases. J Immunol Res. 2016:43264952016. View Article : Google Scholar : PubMed/NCBI

53 

Niu XL, Wang Y, Yao Z, Duan H, Li Z, Liu W, Zhang H and Deng WM: Autocrine interferon-gamma may affect malignant behavior and sensitivity to tamoxifen of MCF-7 via estrogen receptor β subtype. Oncol Rep. 34:3120–3130. 2015. View Article : Google Scholar : PubMed/NCBI

54 

Schultz-Norton JR, McDonald WH, Yates JR and Nardulli AM: Protein disulfide isomerase serves as a molecular chaperone to maintain estrogen receptor alpha structure and function. Mol Endocrinol. 20:1982–1995. 2006. View Article : Google Scholar : PubMed/NCBI

55 

Hashimoto S and Imaoka S: Protein-disulfide isomerase regulates the thyroid hormone receptor-mediated gene expression via redox factor-1 through thiol reduction-oxidation. J Biol Chem. 288:1706–1716. 2013. View Article : Google Scholar : PubMed/NCBI

56 

Mancini A, Bruno C, Vergani E, Guidi F, Angelini F, Meucci E and Silvestrini A: Evaluation of oxidative stress effects on different macromolecules in adult growth hormone deficiency. PLoS One. 15:e02363572020. View Article : Google Scholar : PubMed/NCBI

57 

Boudreau HE, Casterline BW, Burke DJ and Leto TL: Wild-type and mutant p53 differentially regulate NADPH oxidase 4 in TGF-β-mediated migration of human lung and breast epithelial cells. Br J Cancer. 110:2569–2582. 2014. View Article : Google Scholar : PubMed/NCBI

58 

Trevelin SC and Lopes LR: Protein disulfide isomerase and Nox: New partners in redox signaling. Curr Pharm Des. 21:5951–5963. 2015. View Article : Google Scholar : PubMed/NCBI

59 

Lappi AK and Ruddock LW: Reexamination of the role of interplay between glutathione and protein disulfide isomerase. J Mol Biol. 409:238–249. 2011. View Article : Google Scholar : PubMed/NCBI

60 

Hudson DA, Gannon SA and Thorpe C: Oxidative protein folding: From thiol-disulfide exchange reactions to the redox poise of the endoplasmic reticulum. Free Radic Biol Med. 80:171–182. 2015. View Article : Google Scholar : PubMed/NCBI

61 

Coppola S and Ghibelli L: GSH extrusion and and the mitochondrial pathway of apoptotic signalling. Biochem Soc Trans. 28:56–61. 2000. View Article : Google Scholar : PubMed/NCBI

62 

Pedram A, Razandi M, Wallace DC and Levin ER: Functional estrogen receptors in the mitochondria of breast cancer cells. Mol Biol Cell. 17:2125–2137. 2006. View Article : Google Scholar : PubMed/NCBI

63 

Fan Y and Simmen T: Mechanistic connections between endoplasmic reticulum (ER) redox control and mitochondrial metabolism. Cells. 8:10712019. View Article : Google Scholar

64 

Gutierrez T and Simmen T: Endoplasmic reticulum chaperones tweak the mitochondrial calcium rheostat to control metabolism and cell death. Cell Calcium. 70:64–75. 2018. View Article : Google Scholar : PubMed/NCBI

65 

Dikalov S: Cross talk between mitochondria and NADPH oxidases. Free Radic Biol Med. 51:1289–1301. 2011. View Article : Google Scholar : PubMed/NCBI

66 

Kozieł R, Pircher H, Kratochwil M, Lener B, Hermann M, Dencher NA and Jansen-Dürr P: Mitochondrial respiratory chain complex I is inactivated by NADPH oxidase Nox4. Biochem J. 452:231–239. 2013. View Article : Google Scholar : PubMed/NCBI

67 

Kochan G, Escors D, Breckpot K and Guerrero-Setas D: Role of non-classical MHC class I molecules in cancer immunosuppression. Oncoimmunology. 2:e264912013. View Article : Google Scholar : PubMed/NCBI

68 

Xu S, Sankar S and Neamati N: Protein disulfide isomerase: A promising target for cancer therapy. Drug Discov Today. 19:222–240. 2014. View Article : Google Scholar : PubMed/NCBI

69 

Lee E and Lee DH: Emerging roles of protein disulfide isomerase in cancer. BMB Rep. 50:401–410. 2017. View Article : Google Scholar : PubMed/NCBI

70 

Rosenberg N, Mor-Cohen R, Sheptovitsky VH, Romanenco O, Hess O and Lahav J: Integrin-mediated cell adhesion requires extracellular disulfide exchange regulated by protein disulfide isomerase. Exp Cell Res. 381:77–85. 2019. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Alhammad R, Khunchai S, Tongmuang N, Limjindaporn T, Yenchitsomanus PT, Mutti L, Krstic‑Demonacos M and Demonacos C: Protein disulfide isomerase A1 regulates breast cancer cell immunorecognition in a manner dependent on redox state. Oncol Rep 44: 2406-2418, 2020.
APA
Alhammad, R., Khunchai, S., Tongmuang, N., Limjindaporn, T., Yenchitsomanus, P., Mutti, L. ... Demonacos, C. (2020). Protein disulfide isomerase A1 regulates breast cancer cell immunorecognition in a manner dependent on redox state. Oncology Reports, 44, 2406-2418. https://doi.org/10.3892/or.2020.7816
MLA
Alhammad, R., Khunchai, S., Tongmuang, N., Limjindaporn, T., Yenchitsomanus, P., Mutti, L., Krstic‑Demonacos, M., Demonacos, C."Protein disulfide isomerase A1 regulates breast cancer cell immunorecognition in a manner dependent on redox state". Oncology Reports 44.6 (2020): 2406-2418.
Chicago
Alhammad, R., Khunchai, S., Tongmuang, N., Limjindaporn, T., Yenchitsomanus, P., Mutti, L., Krstic‑Demonacos, M., Demonacos, C."Protein disulfide isomerase A1 regulates breast cancer cell immunorecognition in a manner dependent on redox state". Oncology Reports 44, no. 6 (2020): 2406-2418. https://doi.org/10.3892/or.2020.7816
Copy and paste a formatted citation
x
Spandidos Publications style
Alhammad R, Khunchai S, Tongmuang N, Limjindaporn T, Yenchitsomanus PT, Mutti L, Krstic‑Demonacos M and Demonacos C: Protein disulfide isomerase A1 regulates breast cancer cell immunorecognition in a manner dependent on redox state. Oncol Rep 44: 2406-2418, 2020.
APA
Alhammad, R., Khunchai, S., Tongmuang, N., Limjindaporn, T., Yenchitsomanus, P., Mutti, L. ... Demonacos, C. (2020). Protein disulfide isomerase A1 regulates breast cancer cell immunorecognition in a manner dependent on redox state. Oncology Reports, 44, 2406-2418. https://doi.org/10.3892/or.2020.7816
MLA
Alhammad, R., Khunchai, S., Tongmuang, N., Limjindaporn, T., Yenchitsomanus, P., Mutti, L., Krstic‑Demonacos, M., Demonacos, C."Protein disulfide isomerase A1 regulates breast cancer cell immunorecognition in a manner dependent on redox state". Oncology Reports 44.6 (2020): 2406-2418.
Chicago
Alhammad, R., Khunchai, S., Tongmuang, N., Limjindaporn, T., Yenchitsomanus, P., Mutti, L., Krstic‑Demonacos, M., Demonacos, C."Protein disulfide isomerase A1 regulates breast cancer cell immunorecognition in a manner dependent on redox state". Oncology Reports 44, no. 6 (2020): 2406-2418. https://doi.org/10.3892/or.2020.7816
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team